Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Additional File 1 of Diagnostic Yield and Novel Candidate Genes for Neurodevelopmental Disorders by Exome Sequencing in an Unselected Cohort with Microcephaly

Diagnostic Yield and Novel Candidate Genes for Neurodevelopmental Disorders by Exome Sequencing in an Unselected Cohort with Microcephaly

Additional File 4 of the Diagnostic Yield of Intellectual Disability: Combined Whole Genome Low-Coverage Sequencing and Medical Exome Sequencing

Genetic diagnosis of fetal microcephaly at a single tertiary center in China

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Additional File 2 of Characterizing Sensitivity and Coverage of Clinical WGS As a Diagnostic Test for Genetic Disorders

Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders

Additional File 3 of Clinical Efficiency of Simultaneous CNV-seq and Whole-Exome Sequencing for Testing Fetal Structural Anomalies

Diagnostic and Clinical Utility of Next-Generation Sequencing in Children Born with Multiple Congenital Anomalies in the China Neonatal Genomes Project.

Ep098: Exome Sequencing of >500 Individuals with Brain Malformation Phenotypes Reveals Marked Genetic Heterogeneity

Additional File 10: Table S3. of Genome-wide Gene by Lead Exposure Interaction Analysis Identifies UNC5D As a Candidate Gene for Neurodevelopment

Clinical Characterization and Underlying Genetic Findings in Brazilian Patients with Syndromic Microcephaly Associated with Neurodevelopmental Disorders

Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: a Chinese cohort

Genetic Analysis of Children with Unexplained Developmental Delay And/or Intellectual Disability by Whole-Exome Sequencing.

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Targeted sequencing and integrative analysis of 3,195 Chinese patients with neurodevelopmental disorders prioritized 26 novel candidate genes

Additional File 2. of Association of SYNE1 Locus with Bipolar Disorder in Chinese Population

Unexplained Early Infantile Epileptic Encephalopathy in Han Chinese Children: Next-Generation Sequencing and Phenotype Enriching

Genetic and phenotypic analysis of 225 Chinese children with developmental delay and/or intellectual disability using whole-exome sequencing

Use of medical exome sequencing for identification of underlying genetic defects in NICU: Experience in a cohort of 2303 neonates in China